SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001399529-20-000066
Filing Date
2020-09-16
Accepted
2020-09-16 07:39:29
Documents
16
Period of Report
2020-09-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K drna-20200916.htm   iXBRL 8-K 40966
2 EX-99.1 drna20200916ex991.htm EX-99.1 13689
8 image011.jpg GRAPHIC 30618
  Complete submission text file 0001399529-20-000066.txt   242646

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT drna-20200916.xsd EX-101.SCH 2433
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT drna-20200916_cal.xml EX-101.CAL 720
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT drna-20200916_def.xml EX-101.DEF 1657
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT drna-20200916_lab.xml EX-101.LAB 23970
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT drna-20200916_pre.xml EX-101.PRE 12656
9 EXTRACTED XBRL INSTANCE DOCUMENT drna-20200916_htm.xml XML 10940
Mailing Address 33 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 33 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 205993609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36281 | Film No.: 201177415
SIC: 2834 Pharmaceutical Preparations